The U.S. Patent and Trademark Office Has Issued a Patent to Imaging Endpoints and Chief Medical Officer Ron Korn

The U.S. Patent and Trademark Office has issued a patent to Imaging Endpoints and Chief Medical Officer Ron Korn for a new breakthrough radiomic evaluation tool which provides a biomarker for predicting tumor aggressiveness in breast cancer patients. It gives the ability to determine how invasive the treatment should be. Learn more about this breakthrough breast cancer radiomics patent at https://imagingendpoints.com/news/.